Literature DB >> 28515153

Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.

Juan R Muñoz-Castañeda1,2,3,4, Carmen Herencia1,3,5, Maria Victoria Pendón-Ruiz de Mier1,3,5, Maria Encarnación Rodriguez-Ortiz6, Juan M Diaz-Tocados1,3,5, Noemi Vergara1,3,5, Julio M Martínez-Moreno1,3,5, Maria Dolores Salmerón1,3,5, William G Richards7, Arnold Felsenfeld8, Makoto Kuro-O9, Yolanda Almadén1,3,10,11, Mariano Rodríguez12,2,3,4.   

Abstract

In renal failure, hyperphosphatemia occurs despite a marked elevation in serum fibroblast growth factor (FGF)-23. Abnormal regulation of the FGFR1-Klotho receptor complex may cause a resistance to the phosphaturic action of FGF23. The purpose of the present study was to investigate the regulation of renal Klotho and FGF receptor (FEFR)-1 in healthy and uremic rats induced by 5/6 nephrectomy. In normal rats, the infusion of rat recombinant FGF23 enhanced phosphaturia and increased renal FGFR1 expression; however, Klotho expression was reduced. Uremic rats on a high-phosphate (HP) diet presented hyperphosphatemia with marked elevation of FGF23 and an increased fractional excretion of phosphate (P) that was associated with a marked reduction of Klotho expression and an increase in FGFR1. After neutralization of FGF23 by anti-FGF23 administration, phosphaturia was still abundant, Klotho expression remained low, and the FGFR1 level was reduced. These results suggest that the expression of renal Klotho is modulated by phosphaturia, whereas the FGFR1 expression is regulated by FGF23. Calcitriol (CTR) administration prevented a decrease in renal Klotho expression. In HEK293 cells HP produced nuclear translocation of β-catenin, together with a reduction in Klotho. Wnt/β-catenin inhibition with Dkk-1 prevented the P-induced down-regulation of Klotho. The addition of CTR to HP medium was able to recover Klotho expression. In summary, high FGF23 levels increase FGFR1, whereas phosphaturia decreases Klotho expression through the activation of Wnt/β-catenin pathway.-Muñoz-Castañeda, J. R., Herencia, C., Pendón-Ruiz de Mier, M. V., Rodriguez-Ortiz, M. E., Diaz-Tocados, J. M., Vergara, N., Martínez-Moreno, J. M., Salmerón, M. D., Richards, W. G., Felsenfeld, A., Kuro-O, M., Almadén, Y., Rodríguez, M. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. © FASEB.

Entities:  

Keywords:  FGF23; chronic kidney disease; mineral metabolism; phosphaturia

Mesh:

Substances:

Year:  2017        PMID: 28515153     DOI: 10.1096/fj.201700006R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Phosphate and Cellular Senescence.

Authors:  Ming Chang Hu; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Phosphorus restriction does not prevent the increase in fibroblast growth factor 23 elicited by high fat diet.

Authors:  Rafael Rios; Carmen Pineda; Ignacio Lopez; Juan Muñoz-Castañeda; Mariano Rodriguez; Escolastico Aguilera-Tejero; Ana I Raya
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 3.  α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.

Authors:  Reinhold G Erben
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

4.  Hypocaloric Diet Prevents the Decrease in FGF21 Elicited by High Phosphorus Intake.

Authors:  Carmen Pineda; Rafael Rios; Ana I Raya; Mariano Rodriguez; Escolastico Aguilera-Tejero; Ignacio Lopez
Journal:  Nutrients       Date:  2018-10-13       Impact factor: 5.717

5.  Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model.

Authors:  Edgar Maquigussa; Josne C Paterno; Gabriel H de Oliveira Pokorny; Mariana da Silva Perez; Vanessa A Varela; Antônio da Silva Novaes; Nestor Schor; Mirian A Boim
Journal:  Front Physiol       Date:  2018-08-02       Impact factor: 4.566

Review 6.  FGF23, Biomarker or Target?

Authors:  Cristian Rodelo-Haad; Rafael Santamaria; Juan R Muñoz-Castañeda; M Victoria Pendón-Ruiz de Mier; Alejandro Martin-Malo; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2019-03-22       Impact factor: 4.546

Review 7.  New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.

Authors:  Maria L Mace; Klaus Olgaard; Ewa Lewin
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 8.  Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications.

Authors:  Javier A Neyra; Ming Chang Hu; Orson W Moe
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-22       Impact factor: 8.237

9.  Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms.

Authors:  Rafael Santamaría; Juan M Díaz-Tocados; M Victoria Pendón-Ruiz de Mier; Ana Robles; M Dolores Salmerón-Rodríguez; Erena Ruiz; Noemi Vergara; Escolástico Aguilera-Tejero; Ana Raya; Rosa Ortega; Arnold Felsenfeld; Juan R Muñoz-Castañeda; Alejandro Martín-Malo; Pedro Aljama; Mariano Rodríguez
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

Review 10.  Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.

Authors:  Juan Rafael Muñoz-Castañeda; Cristian Rodelo-Haad; Maria Victoria Pendon-Ruiz de Mier; Alejandro Martin-Malo; Rafael Santamaria; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.